Transpara Announces New FDA Clearance Designed to Improve Breast Cancer Detection at RSNA
Hand-out
Press Releases
ScreenPoint Medical  
December 2, 2024

Transpara Announces New FDA Clearance Designed to Improve Breast Cancer Detection at RSNA

ScreenPoint Medical to Showcase Innovative FDA Cleared Capabilities including Breast Density Assessment and Temporal Comparison to Elevate Radiologist Performance

avatar profile Olean Times Herald

Olean Times Herald


Local & Social